XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (1,041,157) $ (748,414)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock compensation 161,349
Depreciation 134
Amortization 2,662 660
Non-cash lease expense 496 1,371
Gain on sale of short-term investments (24,946) (38,772)
Share of net income from equity method investment (5,783)
Changes in operating assets and liabilities:    
Accounts receivable 100 1,325
Accounts receivable - related party 5,603
Prepaid assets 53,693 30,952
Inventory 2,752 (3,900)
Accounts payable - related party (250,000)
Accounts payable (8,024) (353,609)
Accrued expenses 94,429 57,838
Lease liability (4,463) (12,234)
Net cash used in operating activities (763,289) (1,314,649)
Cash flows from investing activities:    
Sale of short-term investments 6,235,053 11,599,356
Purchase of short-term investments (5,439,431) (10,022,293)
Purchase of patents (47,593) (50,196)
Purchase of trademarks (18,715)
Net cash provided by investing activities 729,314 1,526,867
Cash flows from financing activities:    
Payments on notes payable - officer (200,000)
Net cash used in financing activities (200,000)
Net (decrease) increase in cash and cash equivalents (33,975) 12,218
Cash and cash equivalents - beginning of period 580,230 162,743
Cash and cash equivalents - end of period 546,255 174,961
Non-cash investing and financing activities:    
Unrealized gain on short-term investments $ 160 $ 41,069